Stock comparison

BIIBvsUTHR

Biogen IncvsUnited Therapeutics Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

BIIB

Biogen Inc

$187.88

+6.91%

Biotechnology$25.8BNASDAQ

UTHR

United Therapeutics Corp

$572.85

+15.96%

Biotechnology$23.1BNASDAQ

60-day price, rebased to 100

BIIB +6.64% · UTHR +22.59%

Round-by-round

BIIB 2·UTHR 4

EdgeBIIB

Valuation upside

+7.40% vs -10.40% to DCF fair value

EdgeUTHR

Balance-sheet strength

Altman Z 3.10 vs 20.69

EdgeUTHR

Fundamental quality

Piotroski 6.00 vs 7.00 (of 9)

EdgeUTHR

Growth + margins

Rule-of-40 23.00 vs 43.10

EdgeUTHR

60-day momentum

+6.64% vs +22.59% price return

EdgeBIIB

Market-cap liquidity

$25.8B vs $23.1B

Verdict

Across6categories,UTHRtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onBIIBorUTHR

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.